ID   CP4AB_HUMAN             Reviewed;         519 AA.
AC   Q02928; Q06766; Q16865; Q16866; Q5VSP8; Q86SU6; Q8IWY5;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 1.
DT   10-MAY-2017, entry version 162.
DE   RecName: Full=Cytochrome P450 4A11;
DE   AltName: Full=20-hydroxyeicosatetraenoic acid synthase;
DE            Short=20-HETE synthase;
DE   AltName: Full=CYP4AII;
DE   AltName: Full=CYPIVA11;
DE   AltName: Full=Cytochrome P-450HK-omega;
DE   AltName: Full=Cytochrome P450HL-omega;
DE   AltName: Full=Fatty acid omega-hydroxylase;
DE   AltName: Full=Lauric acid omega-hydroxylase;
DE   AltName: Full=Long-chain fatty acid omega-monooxygenase;
DE            EC=1.14.13.205 {ECO:0000269|PubMed:1739747, ECO:0000269|PubMed:7679927};
DE   Flags: Precursor;
GN   Name=CYP4A11; Synonyms=CYP4A2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, CATALYTIC ACTIVITY,
RP   AND TISSUE SPECIFICITY.
RC   TISSUE=Kidney;
RX   PubMed=7679927;
RA   Palmer C.N.A., Richardson T.H., Griffin K.J., Hsu M.-H.,
RA   Muerhoff A.S., Clark J.E., Johnson E.F.;
RT   "Characterization of a cDNA encoding a human kidney, cytochrome P-450
RT   4A fatty acid omega-hydroxylase and the cognate enzyme expressed in
RT   Escherichia coli.";
RL   Biochim. Biophys. Acta 1172:161-166(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), PROTEIN SEQUENCE OF 5-24, AND
RP   CHARACTERIZATION.
RC   TISSUE=Liver;
RX   PubMed=7798189;
RA   Kawashima H., Kusunose E., Kikuta Y., Kinoshita H., Tanaka S.,
RA   Yamamoto S., Kishimoto T., Kusunose M.;
RT   "Purification and cDNA cloning of human liver CYP4A fatty acid omega-
RT   hydroxylase.";
RL   J. Biochem. 116:74-80(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANT SER-434, AND
RP   CHARACTERIZATION.
RC   TISSUE=Kidney;
RX   PubMed=8274222;
RA   Imaoka S., Ogawa H., Kimura S., Gonzalez F.J.;
RT   "Complete cDNA sequence and cDNA-directed expression of CYP4A11, a
RT   fatty acid omega-hydroxylase expressed in human kidney.";
RL   DNA Cell Biol. 12:893-899(1993).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=12464262; DOI=10.1016/S0003-9861(02)00545-3;
RA   Bellamine A., Wang Y., Waterman M.R., Gainer J.V. III, Dawson E.P.,
RA   Brown N.J., Capdevila J.H.;
RT   "Characterization of the CYP4A11 gene, a second CYP4A gene in
RT   humans.";
RL   Arch. Biochem. Biophys. 409:221-227(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1), AND VARIANT SER-434.
RG   SeattleSNPs variation discovery resource;
RL   Submitted (AUG-2003) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PROTEIN SEQUENCE OF 5-39, FUNCTION, AND CATALYTIC ACTIVITY.
RC   TISSUE=Kidney;
RX   PubMed=1739747; DOI=10.1016/0005-2760(92)90106-6;
RA   Kawashima H., Kusunose E., Kubota I., Maekawa M., Kusunose M.;
RT   "Purification and NH2-terminal amino acid sequences of human and rat
RT   kidney fatty acid omega-hydroxylases.";
RL   Biochim. Biophys. Acta 1123:156-162(1992).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 317-457, AND VARIANTS GLY-353 AND
RP   SER-434.
RC   TISSUE=Liver;
RX   PubMed=8363569; DOI=10.1042/bj2940173;
RA   Bell D.R., Plant N.J., Rider C.G., Na L., Brown S., Ateitalla I.,
RA   Acharya S.K., Davies M.H., Elias E.E., Jenkins N.A., Gilbert D.J.,
RA   Copeland N.G., Elcombe C.R.;
RT   "Species-specific induction of cytochrome P-450 4A RNAs: PCR cloning
RT   of partial guinea-pig, human and mouse CYP4A cDNAs.";
RL   Biochem. J. 294:173-180(1993).
RN   [10]
RP   COVALENT HEME ATTACHMENT.
RX   PubMed=11139583; DOI=10.1074/jbc.M009969200;
RA   Hoch U., Ortiz de Montellano P.R.;
RT   "Covalently linked heme in cytochrome P4504A fatty acid
RT   hydroxylases.";
RL   J. Biol. Chem. 276:11339-11346(2001).
RN   [11]
RP   COVALENT HEME ATTACHMENT, AND MUTAGENESIS OF GLU-321.
RX   PubMed=11821421; DOI=10.1074/jbc.M112155200;
RA   LeBrun L.A., Hoch U., Ortiz de Montellano P.R.;
RT   "Autocatalytic mechanism and consequences of covalent heme attachment
RT   in the cytochrome P4504A family.";
RL   J. Biol. Chem. 277:12755-12761(2002).
RN   [12]
RP   FUNCTION, MUTAGENESIS OF GLY-130, AND VARIANT SER-434.
RX   PubMed=15611369; DOI=10.1161/01.CIR.0000151309.82473.59;
RA   Gainer J.V., Bellamine A., Dawson E.P., Womble K.E., Grant S.W.,
RA   Wang Y., Cupples L.A., Guo C.-Y., Demissie S., O'Donnell C.J.,
RA   Brown N.J., Waterman M.R., Capdevila J.H.;
RT   "Functional variant of CYP4A11 20-hydroxyeicosatetraenoic acid
RT   synthase is associated with essential hypertension.";
RL   Circulation 111:63-69(2005).
RN   [13]
RP   VARIANTS GLY-353 AND SER-434.
RX   PubMed=15895287; DOI=10.1007/s10038-005-0245-9;
RA   Cho B.H., Park B.L., Kim L.H., Chung H.S., Shin H.D.;
RT   "Highly polymorphic human CYP4A11 gene.";
RL   J. Hum. Genet. 50:259-263(2005).
CC   -!- FUNCTION: Catalyzes the omega- and (omega-1)-hydroxylation of
CC       various fatty acids such as laurate, myristate and palmitate. Has
CC       little activity toward prostaglandins A1 and E1. Oxidizes
CC       arachidonic acid to 20-hydroxyeicosatetraenoic acid (20-HETE).
CC       {ECO:0000269|PubMed:15611369, ECO:0000269|PubMed:1739747,
CC       ECO:0000269|PubMed:7679927}.
CC   -!- CATALYTIC ACTIVITY: A long-chain fatty acid + NADPH + O(2) = an
CC       omega-hydroxy-long-chain fatty acid + NADP(+) + H(2)O.
CC       {ECO:0000269|PubMed:1739747, ECO:0000269|PubMed:7679927}.
CC   -!- COFACTOR:
CC       Name=heme; Xref=ChEBI:CHEBI:30413;
CC         Evidence={ECO:0000269|PubMed:11139583};
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Peripheral
CC       membrane protein. Microsome membrane; Peripheral membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q02928-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q02928-2; Sequence=VSP_034595;
CC   -!- TISSUE SPECIFICITY: Kidney and liver.
CC       {ECO:0000269|PubMed:7679927}.
CC   -!- POLYMORPHISM: CYP4A11v seems to be a rare allelic variant of
CC       CYP4A11, it seems to be unstable and not to metabolize lauric
CC       acid.
CC   -!- SIMILARITY: Belongs to the cytochrome P450 family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Cytochrome P450 Allele Nomenclature Committee;
CC       Note=CYP4A11 alleles;
CC       URL="http://www.cypalleles.ki.se/cyp4a11.htm";
CC   -!- WEB RESOURCE: Name=SeattleSNPs;
CC       URL="http://pga.gs.washington.edu/data/cyp4a11/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L04751; AAA58436.1; -; mRNA.
DR   EMBL; D26481; BAA05491.1; -; mRNA.
DR   EMBL; S67580; AAB29502.1; -; mRNA.
DR   EMBL; S67581; AAB29503.1; -; mRNA.
DR   EMBL; AF525488; AAO16078.1; -; Genomic_DNA.
DR   EMBL; AY369778; AAQ56847.1; -; Genomic_DNA.
DR   EMBL; AL731892; CAH72778.1; -; Genomic_DNA.
DR   EMBL; AL731892; CAH72779.1; -; Genomic_DNA.
DR   EMBL; BC041158; AAH41158.1; -; mRNA.
DR   EMBL; X71480; CAA50586.1; -; mRNA.
DR   CCDS; CCDS543.1; -. [Q02928-1]
DR   PIR; A56859; A56859.
DR   PIR; I53015; I53015.
DR   PIR; I65981; I65981.
DR   PIR; JX0331; JX0331.
DR   RefSeq; NP_000769.2; NM_000778.3. [Q02928-1]
DR   RefSeq; NP_001306084.1; NM_001319155.1.
DR   UniGene; Hs.1645; -.
DR   UniGene; Hs.726474; -.
DR   ProteinModelPortal; Q02928; -.
DR   SMR; Q02928; -.
DR   BioGrid; 107951; 4.
DR   IntAct; Q02928; 1.
DR   STRING; 9606.ENSP00000311095; -.
DR   ChEMBL; CHEMBL3978; -.
DR   DrugBank; DB00515; Cisplatin.
DR   DrugBank; DB00636; Clofibrate.
DR   DrugBank; DB01234; Dexamethasone.
DR   DrugBank; DB00655; Estrone.
DR   DrugBank; DB00898; Ethanol.
DR   DrugBank; DB00448; Lansoprazole.
DR   DrugBank; DB00157; NADH.
DR   DrugBank; DB00082; Pegvisomant.
DR   DrugBank; DB00738; Pentamidine.
DR   DrugBank; DB01174; Phenobarbital.
DR   DrugBank; DB04977; Plitidepsin.
DR   DrugBank; DB01045; Rifampicin.
DR   DrugBank; DB00755; Tretinoin.
DR   SwissLipids; SLP:000000398; -.
DR   iPTMnet; Q02928; -.
DR   PhosphoSitePlus; Q02928; -.
DR   BioMuta; CYP4A11; -.
DR   DMDM; 2493371; -.
DR   PaxDb; Q02928; -.
DR   PeptideAtlas; Q02928; -.
DR   PRIDE; Q02928; -.
DR   Ensembl; ENST00000310638; ENSP00000311095; ENSG00000187048. [Q02928-1]
DR   GeneID; 1579; -.
DR   KEGG; hsa:1579; -.
DR   UCSC; uc001cqp.5; human. [Q02928-1]
DR   CTD; 1579; -.
DR   DisGeNET; 1579; -.
DR   GeneCards; CYP4A11; -.
DR   HGNC; HGNC:2642; CYP4A11.
DR   MIM; 601310; gene.
DR   neXtProt; NX_Q02928; -.
DR   OpenTargets; ENSG00000187048; -.
DR   PharmGKB; PA27118; -.
DR   eggNOG; KOG0157; Eukaryota.
DR   eggNOG; COG2124; LUCA.
DR   GeneTree; ENSGT00760000118816; -.
DR   HOVERGEN; HBG000182; -.
DR   InParanoid; Q02928; -.
DR   KO; K17687; -.
DR   PhylomeDB; Q02928; -.
DR   TreeFam; TF105088; -.
DR   Reactome; R-HSA-1989781; PPARA activates gene expression.
DR   Reactome; R-HSA-211935; Fatty acids.
DR   Reactome; R-HSA-211958; Miscellaneous substrates.
DR   Reactome; R-HSA-211979; Eicosanoids.
DR   Reactome; R-HSA-2142691; Synthesis of Leukotrienes (LT) and Eoxins (EX).
DR   Reactome; R-HSA-2142816; Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE).
DR   ChiTaRS; CYP4A11; human.
DR   GeneWiki; CYP4A11; -.
DR   GenomeRNAi; 1579; -.
DR   PRO; PR:Q02928; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000187048; -.
DR   CleanEx; HS_CYP4A11; -.
DR   ExpressionAtlas; Q02928; baseline and differential.
DR   Genevisible; Q02928; HS.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:UniProtKB.
DR   GO; GO:0031090; C:organelle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0018685; F:alkane 1-monooxygenase activity; IDA:BHF-UCL.
DR   GO; GO:0008392; F:arachidonic acid epoxygenase activity; IDA:UniProtKB.
DR   GO; GO:0020037; F:heme binding; IEA:InterPro.
DR   GO; GO:0005506; F:iron ion binding; IEA:InterPro.
DR   GO; GO:0050051; F:leukotriene-B4 20-monooxygenase activity; IDA:UniProtKB.
DR   GO; GO:0004497; F:monooxygenase activity; TAS:Reactome.
DR   GO; GO:0019825; F:oxygen binding; TAS:Reactome.
DR   GO; GO:0019369; P:arachidonic acid metabolic process; IDA:UniProtKB.
DR   GO; GO:0019373; P:epoxygenase P450 pathway; IDA:UniProtKB.
DR   GO; GO:0006631; P:fatty acid metabolic process; TAS:Reactome.
DR   GO; GO:0006691; P:leukotriene metabolic process; IDA:UniProtKB.
DR   GO; GO:0001676; P:long-chain fatty acid metabolic process; IDA:BHF-UCL.
DR   GO; GO:0097267; P:omega-hydroxylase P450 pathway; TAS:Reactome.
DR   GO; GO:0055114; P:oxidation-reduction process; IDA:UniProtKB.
DR   GO; GO:0032305; P:positive regulation of icosanoid secretion; IMP:UniProtKB.
DR   GO; GO:0003095; P:pressure natriuresis; IEP:UniProtKB.
DR   GO; GO:0003091; P:renal water homeostasis; IEP:UniProtKB.
DR   GO; GO:0055078; P:sodium ion homeostasis; IEP:UniProtKB.
DR   InterPro; IPR001128; Cyt_P450.
DR   InterPro; IPR017972; Cyt_P450_CS.
DR   InterPro; IPR002401; Cyt_P450_E_grp-I.
DR   Pfam; PF00067; p450; 1.
DR   PRINTS; PR00463; EP450I.
DR   PRINTS; PR00385; P450.
DR   SUPFAM; SSF48264; SSF48264; 1.
DR   PROSITE; PS00086; CYTOCHROME_P450; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Direct protein sequencing;
KW   Endoplasmic reticulum; Heme; Iron; Membrane; Metal-binding; Microsome;
KW   Monooxygenase; NADP; Oxidoreductase; Phosphoprotein; Polymorphism;
KW   Reference proteome.
FT   INIT_MET      1      1       Removed. {ECO:0000250|UniProtKB:Q9GJX5}.
FT   PROPEP        2      4       {ECO:0000269|PubMed:1739747,
FT                                ECO:0000269|PubMed:7798189}.
FT                                /FTId=PRO_0000003579.
FT   CHAIN         5    519       Cytochrome P450 4A11.
FT                                /FTId=PRO_0000003580.
FT   COMPBIAS     24     31       Poly-Leu.
FT   COMPBIAS    131    134       Poly-Leu.
FT   METAL       457    457       Iron (heme axial ligand).
FT                                {ECO:0000269|PubMed:11139583}.
FT   BINDING     321    321       Heme (covalent; via 1 link).
FT                                {ECO:0000269|PubMed:11139583}.
FT   MOD_RES     440    440       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P20816}.
FT   VAR_SEQ     356    519       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_034595.
FT   VARIANT     226    226       N -> S (in dbSNP:rs12759923).
FT                                /FTId=VAR_048452.
FT   VARIANT     353    353       S -> G (in dbSNP:rs3899049).
FT                                {ECO:0000269|PubMed:15895287,
FT                                ECO:0000269|PubMed:8363569}.
FT                                /FTId=VAR_044377.
FT   VARIANT     434    434       F -> S (associated with hypertension;
FT                                significantly reduced arachidonic acid
FT                                and lauric acid metabolizing activity;
FT                                dbSNP:rs1126742).
FT                                {ECO:0000269|PubMed:15611369,
FT                                ECO:0000269|PubMed:15895287,
FT                                ECO:0000269|PubMed:8274222,
FT                                ECO:0000269|PubMed:8363569,
FT                                ECO:0000269|Ref.5}.
FT                                /FTId=VAR_019160.
FT   VARIANT     500    519       NGIHLRLRRLPNPCEDKDQL -> MESTCVSGGSLTLVKTR
FT                                TSFEGLHLPSCLPDPRFCPLPVCPYPVFCLPTFPSSHLPAV
FT                                PQSACPSLSHLSPGLPTCLSTCLLPTCISCWEKS (in
FT                                CYP4A11V).
FT                                /FTId=VAR_001257.
FT   MUTAGEN     130    130       G->S: Loss of activity.
FT                                {ECO:0000269|PubMed:15611369}.
FT   MUTAGEN     321    321       E->A: Loss of covalent heme binding.
FT                                {ECO:0000269|PubMed:11821421}.
FT   CONFLICT      5      5       V -> A (in Ref. 8; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    383    383       Y -> F (in Ref. 4; AAO16078).
FT                                {ECO:0000305}.
FT   CONFLICT    390    390       G -> S (in Ref. 9; CAA50586).
FT                                {ECO:0000305}.
FT   CONFLICT    410    412       MVL -> TVM (in Ref. 9; CAA50586).
FT                                {ECO:0000305}.
SQ   SEQUENCE   519 AA;  59348 MW;  A8D3073EEFF48AE9 CRC64;
     MSVSVLSPSR LLGDVSGILQ AASLLILLLL LIKAVQLYLH RQWLLKALQQ FPCPPSHWLF
     GHIQELQQDQ ELQRIQKWVE TFPSACPHWL WGGKVRVQLY DPDYMKVILG RSDPKSHGSY
     RFLAPWIGYG LLLLNGQTWF QHRRMLTPAF HYDILKPYVG LMADSVRVML DKWEELLGQD
     SPLEVFQHVS LMTLDTIMKC AFSHQGSIQV DRNSQSYIQA ISDLNNLVFS RVRNAFHQND
     TIYSLTSAGR WTHRACQLAH QHTDQVIQLR KAQLQKEGEL EKIKRKRHLD FLDILLLAKM
     ENGSILSDKD LRAEVDTFMF EGHDTTASGI SWILYALATH PKHQERCREE IHSLLGDGAS
     ITWNHLDQMP YTTMCIKEAL RLYPPVPGIG RELSTPVTFP DGRSLPKGIM VLLSIYGLHH
     NPKVWPNPEV FDPFRFAPGS AQHSHAFLPF SGGSRNCIGK QFAMNELKVA TALTLLRFEL
     LPDPTRIPIP IARLVLKSKN GIHLRLRRLP NPCEDKDQL
//
